Functionally, forced IGF1R activation in QBC-939 and RBE cells enhanced proliferation, invasion and orthotopic tumor growth, whereas pharmacologic or genetic blockade produced the opposite phenotype, confirming a causal role for IGF1R in disease aggressiveness. The gene discussed is IGF1R; the disease is neoplasm.